/Companies

Combat

2 known investors

Find your way into Combat

Each arrow is one introduction. Sign up to fill in the first one.

177 people can intro you to Edward

Ask Ronnie Potel to introduce you to Edward Bruce-White

You →Ronnie · together at Combat →Edward

Sign up to find every way you can get introduced to Combat

  • Your email: who you already know at Combat, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Combat team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.

Founders & leadership

EBEdward Bruce-White
Edward Bruce-WhiteCEO/Co-FounderEdward Bruce-White is CEO and co-founder of Combatcancer, a clinical-stage cancer treatment company developing therapies for bladder and prostate cancer. He brings over 20 years of experience in medical device product development, commercialization, and business strategy, with a background that includes managing major corporate transactions, IPOs, and M&A activities.
AMAlberto Martinez Albalat
Alberto Martinez AlbalatDirector of R&D, Founder and Chairman

Investors · 2

Frequently asked questions

What does Combat do?
Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
Who founded Combat?
Combat was founded by Edward Bruce-White, Alberto Martinez Albalat.
Who are Combat's investors?
Combat's investors include Oxford Technology Management, NW Angel.